Figure 1: Changes in body weight from baseline to the end of treatment at week 26 associated with the trial product estimand, in the randomly assigned treatment groups administered either 0.3 mg of cagrilintide, 0.6 mg of cagrilintide, 1.2 mg of cagrilintide, 2.5 mg of cagrilintide, 4.5 mg of cagrilintide, 3.0 mg of liraglutide, or a placebo
Methods Reagents and drugs L-carnitine, H 2 O 2 , MTT, 2',7'-dichlorfluorescein-diacetate (DCFH-DA) and MK886 were purchased from Sigma-Aldrich (St Louis, MO, USA)
Semaglutide addresses hunger and fullness cues, while B12 supports metabolic function and energy
It reported increased explant outgrowth, cell survival under stress and migration associated with FAK-paxillin signalling